Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratympanic dexamethasone and lidocaine for tinnitus in otitis media / sudden sensorineural hearing loss
IRCT20251014067616N1Phase 3Recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexamethasone and lidocaine in tinnitus, acute sensorineural hearing loss and otitis media, sponsored by Tehran University of Medical Sciences. Started Oct 2025; status: recruiting.
02
Drugs
dexamethasonelidocaine
03
Conditions
tinnitusacute sensorineural hearing lossotitis media
Beyond the preview
Go deeper on IRCT20251014067616N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251014067616N1.